Back

Pulsed-field ablation versus radiofrequency ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Novel insights in catheter ablation of atrial fibrillation Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Ines Martins Esteves

Abel Salazar Biomedical Sciences Institute (ICBAS), Porto (Portugal)

7 More presentations in this session

Presentation thumbnail
Hemolysis biomarkers after pulmonary vein isolation using three different pulsed-field ablation systems
Mr J. Bruegger (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Is catheter ablation in atrial fibrillation patients with functional tricuspid regurgitation as effective as in patients with functional mitral regurgitation?
Doctor Y. Sumiyama (Nishinomiya, JP)
Abstract Slides Video
Presentation thumbnail
Patients with patent foramen ovale or atrial septal defect have worse outcomes after pulmonary vein isolation
Mr S. Bajrami (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Bachmanns bundle related atrial tachycardias following catheter ablation of persistent atrial fibrillation
Doctor N. Christian-Miller (Ann Arbor, US)
Abstract Slides Video
Presentation thumbnail
31 vs. 35 mm: pulsed-field ablation with two different-sized pentaspline catheters for the treatment of atrial fibrillation
Doctor C. Isenegger (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights in catheter ablation of atrial fibrillation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Evidence on efficacy and safety of pulsed field ablation for atrial fibrillation ablation
thumbnail
Congress Session
Pulsed field ablation for atrial fibrillation ablation: latest findings
thumbnail
Congress Presentation
Pulsed-field ablation versus conventional thermal ablation for atrial fibrillation: a meta-analysis of randomised controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources